English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Tandem Diabetes Care
Patient Daily
| May 7, 2023
Tandem Diabetes Care Announces First Quarter 2023 Financial Results and Reaffirms Full Year 2023 Financial Guidance
Patient Daily
| Apr 24, 2023
Tandem Diabetes Care to Present at the BofA Securities 2023 Health Care Conference
Patient Daily
| Apr 24, 2023
Tandem Diabetes Care Announces Control-IQ Technology Meta-analysis Demonstrating Positive Clinical Impact of Automatic Correction Bolusing on Glucose Control in People with Type 1 Diabetes
Trending
+
Pharmaceuticals
Patient Daily
| Jun 10, 2025
Radiation oncologist on 340B program: ‘It is used as a consolidation tool by large institutions to kill competition in the market’
+
Pharmaceuticals
Patient Daily
| Jun 5, 2025
Exon 20 Group questions effectiveness of 340B drug program
+
Pharmaceuticals
Patient Daily
| Jun 9, 2025
Director of Public Affairs of PhRMA: ‘There is also evidence that 340B is harming state and federal budgets’
+
Pharmaceuticals
Patient Daily
| Jun 5, 2025
New study identifies indicators for HER2+ breast cancer therapy response
